A detailed history of Deutsche Bank Ag\ transactions in Novo Cure LTD stock. As of the latest transaction made, Deutsche Bank Ag\ holds 161,034 shares of NVCR stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,034
Previous 120,502 33.64%
Holding current value
$2.72 Million
Previous $2.06 Million 21.9%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.61 - $23.34 $632,704 - $946,016
40,532 Added 33.64%
161,034 $2.52 Million
Q2 2024

Aug 14, 2024

BUY
$11.83 - $24.05 $510,038 - $1.04 Million
43,114 Added 55.71%
120,502 $2.06 Million
Q1 2024

May 15, 2024

BUY
$12.42 - $17.29 $5,216 - $7,261
420 Added 0.55%
77,388 $1.21 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $699,420 - $991,630
62,841 Added 444.83%
76,968 $1.15 Million
Q3 2023

Nov 09, 2023

SELL
$16.15 - $42.35 $1.87 Million - $4.89 Million
-115,555 Reduced 89.11%
14,127 $228,000
Q2 2023

Aug 14, 2023

SELL
$40.29 - $82.51 $2.96 Million - $6.07 Million
-73,534 Reduced 36.19%
129,682 $5.38 Million
Q1 2023

May 15, 2023

SELL
$56.44 - $118.81 $513,491 - $1.08 Million
-9,098 Reduced 4.29%
203,216 $12.2 Million
Q4 2022

Feb 13, 2023

SELL
$63.98 - $85.37 $162,189 - $216,412
-2,535 Reduced 1.18%
212,314 $15.6 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $219,403 - $289,042
3,227 Added 1.52%
214,849 $16.3 Million
Q2 2022

Aug 11, 2022

SELL
$56.6 - $89.9 $436,046 - $692,589
-7,704 Reduced 3.51%
211,622 $14.7 Million
Q1 2022

May 13, 2022

BUY
$60.15 - $84.52 $629,830 - $885,008
10,471 Added 5.01%
219,326 $18.2 Million
Q4 2021

Feb 11, 2022

SELL
$75.08 - $121.99 $1.22 Million - $1.98 Million
-16,271 Reduced 7.23%
208,855 $15.7 Million
Q3 2021

Nov 04, 2021

SELL
$116.17 - $194.55 $295,420 - $494,740
-2,543 Reduced 1.12%
225,126 $26.2 Million
Q2 2021

Aug 11, 2021

BUY
$130.4 - $225.58 $7.1 Million - $12.3 Million
54,482 Added 31.46%
227,669 $50.5 Million
Q1 2021

May 13, 2021

BUY
$124.11 - $190.17 $9.54 Million - $14.6 Million
76,842 Added 79.76%
173,187 $22.9 Million
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $1.59 Million - $2.47 Million
14,211 Added 17.3%
96,345 $16.7 Million
Q3 2020

Nov 12, 2020

BUY
$58.05 - $111.31 $3.46 Million - $6.64 Million
59,653 Added 265.35%
82,134 $9.14 Million
Q2 2020

Aug 13, 2020

SELL
$57.2 - $74.41 $1.05 Million - $1.37 Million
-18,394 Reduced 45.0%
22,481 $1.33 Million
Q1 2020

May 14, 2020

BUY
$57.05 - $95.75 $234,190 - $393,053
4,105 Added 11.16%
40,875 $2.75 Million
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $3.35 Million - $4.61 Million
-49,117 Reduced 57.19%
36,770 $3.1 Million
Q3 2019

Nov 14, 2019

SELL
$61.86 - $97.8 $10.8 Million - $17.1 Million
-175,323 Reduced 67.12%
85,887 $6.42 Million
Q2 2019

Aug 14, 2019

BUY
$42.22 - $63.23 $1.99 Million - $2.97 Million
47,023 Added 21.95%
261,210 $16.5 Million
Q1 2019

May 15, 2019

BUY
$31.96 - $56.12 $4.32 Million - $7.58 Million
135,032 Added 170.59%
214,187 $10.3 Million
Q4 2018

Feb 14, 2019

SELL
$28.72 - $52.63 $3.85 Million - $7.06 Million
-134,131 Reduced 62.89%
79,155 $2.65 Million
Q3 2018

Dec 21, 2021

BUY
$32.0 - $52.4 $1.06 Million - $1.73 Million
33,064 Added 18.35%
213,286 $11.2 Million
Q3 2018

Nov 14, 2018

SELL
$32.0 - $52.4 $4.12 Million - $6.75 Million
-128,733 Reduced 41.67%
180,222 $9.44 Million
Q2 2018

Apr 21, 2020

BUY
$19.85 - $32.0 $753,188 - $1.21 Million
37,944 Added 14.0%
308,955 $9.67 Million
Q2 2018

Aug 14, 2018

BUY
$19.85 - $32.0 $2.85 Million - $4.6 Million
143,696 Added 112.87%
271,011 $8.48 Million
Q1 2018

Oct 18, 2019

BUY
$19.3 - $23.65 $574,117 - $703,516
29,747 Added 30.49%
127,315 $2.77 Million
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $3.62 Million - $4.44 Million
-187,722 Reduced 65.8%
97,568 $2.13 Million
Q4 2017

Feb 14, 2018

BUY
$16.3 - $21.9 $3.72 Million - $5 Million
228,319 Added 400.76%
285,290 $5.76 Million
Q3 2017

Nov 14, 2017

BUY
$18.05 - $21.75 $1.03 Million - $1.24 Million
56,971
56,971 $1.13 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.77B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.